Justin Stebbing is a leading oncology expert. He has published over 500 peer-reviewed papers in journals including The New England Journal of Medicine, Blood, The Lancet and The Journal of Clinical Oncology, and is co-Editor-in-Chief of Oncogene. In addition, Dr. Stebbing has an extensive clinical practice and links this to a wide number of translational research studies.
Dr. Stebbing is a Fellow of the Royal College of Physicians and the Royal College of Pathologists and has been awarded the first NIHR translational research professorship in oncology from Great Britain’s National Institute for Health Research.
He has extensive biopharma investment experience, has previously served as an advisor to Atticus Capital and currently advises Lansdowne Partners. Dr. Stebbing earned his medical degree from Trinity College, Oxford, completed his residency at The Johns Hopkins Hospital in Baltimore, Maryland and received his PhD from Imperial College, London.